Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Substance Name: Riluzole
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Agreement between physician's recommendation and fitness-to-drive decision in multiple sclerosis.
Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?
Neuromyelitis Optica With Onset in Childhood and Adolescence.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
[Neuromyelitis optica in the elderly: An unusual demyelinating disease.]
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
NMO spectrum presenting as partial myelitis.
Structure and Activity of the Acid Sensing Ion Channels.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Cognitive rehabilitation correlates with the functional connectivity of the anterior cingulate cortex in patients with multiple sclerosis.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
The Spectrum of Neuromyelitis Optica (NMO) in Childhood.
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Resolution of autoimmune thrombocytopenia associated with raltegravir use in an HIV-positive patient.
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?

Pages